Cargando…

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

CONTEXT: Therapeutic doxorubicin administration is restricted as this anticancer drug may be cardiotoxic. The traditional Chinese medicine qiliqiangxin has been approved for clinical treatment of chronic heart failure. OBJECTIVE: To explore the protective effects and molecular mechanisms of qiliqian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Xutao, Chen, Guozhen, Xie, Ying, Jiang, Deyou, Han, Jieru, Chen, Fei, Song, Yunjia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301709/ https://www.ncbi.nlm.nih.gov/pubmed/32429724 http://dx.doi.org/10.1080/13880209.2020.1761403

Ejemplares similares

Shenlijia Attenuates Doxorubicin-Induced Chronic Heart Failure by Inhibiting Cardiac Fibrosis
por: Sun, Xutao, et al.
Publicado: (2021)

Qiliqiangxin Capsule Improves Cardiac Function and Attenuates Cardiac Remodeling by Upregulating miR-133a after Myocardial Infarction in Rats
por: Chen, Huiyang, et al.
Publicado: (2019)

Qiliqiangxin Capsules Optimize Cardiac Metabolism Flexibility in Rats With Heart Failure After Myocardial Infarction
por: Cheng, Wenkun, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin attenuates cardiac remodeling after acute myocardial infarction in mice
por: Tao, Lichan, et al.
Publicado: (2015)

The Electrophysiological Effects of Qiliqiangxin on Cardiac Ventricular Myocytes of Rats
por: Wei, Yidong, et al.
Publicado: (2013)

Traditional Chinese Medication Qiliqiangxin Protects Against Cardiac Remodeling and Dysfunction in Spontaneously Hypertensive Rats
por: Wang, Hui, et al.
Publicado: (2017)

Qiliqiangxin Modulates the Gut Microbiota and NLRP3 Inflammasome to Protect Against Ventricular Remodeling in Heart Failure
por: Lu, Yingdong, et al.
Publicado: (2022)

Future prospects of Qiliqiangxin on heart failure: epigenetic regulation of regeneration
por: Tao, Lichan, et al.
Publicado: (2013)

Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats
por: Wang, Jingfeng, et al.
Publicado: (2017)

Qiliqiangxin inhibits angiotensin II-induced transdifferentiation of rat cardiac fibroblasts through suppressing interleukin-6
por: Zhou, Jingmin, et al.
Publicado: (2015)

Protective Effect of Qiliqiangxin against Doxorubicin-Induced Cardiomyopathy by Suppressing Excessive Autophagy and Apoptosis
por: Qin, Yating, et al.
Publicado: (2022)

Protective Effect of Qiliqiangxin Capsule on Energy Metabolism and Myocardial Mitochondria in Pressure Overload Heart Failure Rats
por: Zhang, Junfang, et al.
Publicado: (2013)

A metabolomics study of Qiliqiangxin in a rat model of heart failure: a reverse pharmacology approach
por: Fu, Junzeng, et al.
Publicado: (2018)

Combination Treatment With Antihypertensive Agents Enhances the Effect of Qiliqiangxin on Chronic Pressure Overload–induced Cardiac Hypertrophy and Remodeling in Male Mice
por: Ye, Yong, et al.
Publicado: (2015)

Qiliqiangxin attenuates hypoxia‐induced injury in primary rat cardiac microvascular endothelial cells via promoting HIF‐1α‐dependent glycolysis
por: Wang, Yanyan, et al.
Publicado: (2018)

Lingguizhugan decoction attenuates doxorubicin-induced heart failure in rats by improving TT-SR microstructural remodeling
por: Li, Xueping, et al.
Publicado: (2019)

Qiliqiangxin Improves Cardiac Function through Regulating Energy Metabolism via HIF-1α-Dependent and Independent Mechanisms in Heart Failure Rats after Acute Myocardial Infarction
por: Wang, Yanyan, et al.
Publicado: (2020)

Qiliqiangxin Affects L Type Ca(2+) Current in the Normal and Hypertrophied Rat Heart
por: Wei, Yidong, et al.
Publicado: (2012)

Regulation of energy metabolism by combination therapy attenuates cardiac metabolic remodeling in heart failure
por: Huang, Yuting, et al.
Publicado: (2020)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure
por: Machackova, Jarmila, et al.
Publicado: (2011)

Pachymic Acid Attenuated Doxorubicin-Induced Heart Failure by Suppressing miR-24 and Preserving Cardiac Junctophilin-2 in Rats
por: Younis, Nahla N., et al.
Publicado: (2021)

Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2010)

Tracing triggers of cardiac remodelling and heart failure
por: van Driel, B. O., et al.
Publicado: (2021)

Higenamine Attenuates Doxorubicin-Induced Cardiac Remodeling and Myocyte Apoptosis by Suppressing AMPK Activation
por: Jin, Cuiliu, et al.
Publicado: (2022)

Sotagliflozin attenuates cardiac dysfunction and remodeling in myocardial infarction rats
por: Zhong, Peng, et al.
Publicado: (2023)

N‐acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure
por: Giam, Beverly, et al.
Publicado: (2016)

Remote Ischemic Pre-Conditioning Attenuates Adverse Cardiac Remodeling and Mortality Following Doxorubicin Administration in Mice
por: Gertz, Zachary M., et al.
Publicado: (2019)

Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
por: de Boer, Rudolf A., et al.
Publicado: (2012)

Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats
por: Liao, Ying, et al.
Publicado: (2018)

Zisheng Shenqi Decoction Ameliorates Monosodium Urate-Mediated Gouty Arthritis in Rats via Promotion of Autophagy through the AMPK/mTOR Signaling Pathway
por: Han, Jieru, et al.
Publicado: (2021)

Integrating Pharmacokinetics Study, Network Analysis, and Experimental Validation to Uncover the Mechanism of Qiliqiangxin Capsule Against Chronic Heart Failure
por: Zhang, Yu, et al.
Publicado: (2019)

The Efficacy and Safety of a Qiliqiangxin Capsule Combined with Sacubitril/Valsartan in the Treatment of Chronic Heart Failure: A Systematic Review and Meta-Analysis
por: Chen, Wensheng, et al.
Publicado: (2023)

Cardiac contractility modulation attenuates structural and electrical remodeling in a chronic heart failure rabbit model
por: Ning, Bin, et al.
Publicado: (2020)

Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling
por: Zhang, Jie, et al.
Publicado: (2017)

Thymoquinone protects against cardiac damage from doxorubicin-induced heart failure in Sprague-Dawley rats
por: Pei, Zuowei, et al.
Publicado: (2018)

Intermedin in the Paraventricular Nucleus Attenuates Cardiac Sympathetic Afferent Reflex in Chronic Heart Failure Rats
por: Gan, Xian-Bing, et al.
Publicado: (2014)

Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction
por: Zhang, Liyun, et al.
Publicado: (2021)

Autonomic dysfunction is associated with cardiac remodelling in heart failure patients
por: Ali, Amna, et al.
Publicado: (2017)

Metabolomic signatures of cardiac remodelling and heart failure risk in the community
por: Andersson, Charlotte, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gajqemaavdec702q99bin8teiu